Suchergebnisse - "Hierl, Markus"

PubPharm (21)

1

Selective and brain-penetrant HCN1 inhibitors reveal links between synaptic integration, cortical function, and working memory

enthalten in: Cell chemical biology | 2024

von Harde, E. | Hierl, M. | Weber, M. | +17

2

Emerging Gene Therapeutics for Epidermolysis Bullosa under Development

enthalten in: International journal of molecular sciences | 2024

von Bischof, J. | Hierl, M. | Koller, U.

3

KV3 ENHANCERS FOR THE TREATMENT OF COGNITIVE DISORDERS

enthalten in: Europäisches Patentamt | 2023

von GUNDLFINGER ANJA | HALL BENJAMIN JOHN | HIERL MARKUS ROBERT | +6

4

Tritium Labeling of Neuromedin S by Conjugation with [3H]N-Succinimidyl Propionate

enthalten in: ACS omega | 2023

von Edelmann, M. | Erny, J. | Guba, W. | +1

5

ALKYNYL-(HETEROARYL)-CARBOXAMIDE HCN1 INHIBITORS

enthalten in: Europäisches Patentamt | 2022

von BARTELS BJOERN | DUPONT AMANDA LEE | HALL BENJAMIN J | +8

6

KV3 ENHANCERS FOR THE TREATMENT OF COGNITIVE DISORDERS

enthalten in: Europäisches Patentamt | 2021

von GUNDLFINGER ANJA | HALL BENJAMIN JOHN | HIERL MARKUS ROBERT | +6

7

High-throughput TR-FRET assays for identifying inhibitors of LSD1 and JMJD2C histone lysine demethylases

enthalten in: Journal of biomolecular screening | 2012

von Yu, V. | Fisch, T. | Long, A. | +7

8

High-Throughput TR-FRET Assays for Identifying Inhibitors of LSD1 and JMJD2C Histone Lysine Demethylases

enthalten in: Journal of biomolecular screening | 2012

von Yu, V. | Fisch, T. | Long, A. | +7

9

Identification of a potent, state-dependent inhibitor of Nav1.7 with oral efficacy in the formalin model of persistent pain

enthalten in: Journal of medicinal chemistry | 2011

von Bregman, H. | Berry, L. | Buchanan, J. | +23

10

Identification of a Potent, State-Dependent Inhibitor of Nav1.7 with Oral Efficacy in the Formalin Model of Persistent Pain

enthalten in: Journal of medicinal chemistry | 2011

von Bregman, H. | Berry, L. | Buchanan, J. | +23